Book contents
- Clinical Textbook of Mood Disorders
- Clinical Textbook of Mood Disorders
- Copyright page
- Contents
- Contributors
- Foreword
- Chapter 1 Mood Disorders in the Twenty-First Century
- Chapter 2 The Classification of Mood Disorders and the Unipolar/Bipolar Dichotomy
- Chapter 3 Epidemiology of Mood Disorders across the Life Span
- Chapter 4 The Mood Spectrum Concept: Clinical Implications
- Chapter 5 Clinical Screening for Unipolar and Bipolar Disorders
- Chapter 6 The Socioeconomic Costs of Mood Disorders
- Chapter 7 Mood Disorders and Suicide
- Chapter 8 Mood and Psychosis: Limits and Overlapping between Psychotic Disorders and Mood Disorders
- Chapter 9 Transcultural Issues in Mood Disorders
- Chapter 10 Mood Disorders and Stress-Related Disorders
- Chapter 11 The Common Ancestors of Anxiety and Depression: Comorbidity as a Cognitive, Behavioural, Neural and Cellular Phenotype, and Current Evidence for Photobiomodulation as a Novel Treatment
- Chapter 12 Mood Disorders and Comorbid Substance Use Disorders
- Chapter 13 Mood Disorders with Attention-Deficit/Hyperactivity Disorder, Impulse Control Disorders, or Borderline Personality Disorder
- Chapter 14 Phenomenological Psychopathology of Mood Disorders
- Chapter 15 Brain Imaging in Mood Disorders: Pathophysiological Significance and Clinical Perspectives
- Chapter 16 Inflammation and Metabolic Issues in Mood Disorders
- Chapter 17 Genetics of Mood Disorders
- Chapter 18 Management of Major Depressive Disorder: Basic Principles
- Chapter 19 Treatment-Resistant Depression: Pharmacological Approach
- Chapter 20 An Update on the Treatment of Manic and Hypomanic States
- Chapter 21 The Burden of Bipolar Depression
- Chapter 22 The Management of Neurocognitive Impairment in Mood Disorders
- Chapter 23 Progress in Biomarkers to Improve Treatment Outcomes in Major Depressive Disorder
- Chapter 24 Pharmacogenomics and the Management of Mood Disorders
- Chapter 25 Mood Disorders: Therapeutic Challenges in the Medically Ill Patient
- Chapter 26 The Treatment of Mood Disorders in Children and Adolescents
- Chapter 27 Considerations about the Treatment of Mood Disorders in Elderly Patients
- Chapter 28 Evidence-Based Psychological Interventions for Bipolar Disorders
- Chapter 29 Evidence-Based Psychotherapeutic Approaches for Depressive Disorders
- Chapter 30 Rating Instruments for Mood Disorders in Clinical Practice
- Chapter 31 Service Delivery for Mood Disorders
- Index
- References
Chapter 15 - Brain Imaging in Mood Disorders: Pathophysiological Significance and Clinical Perspectives
Published online by Cambridge University Press: 16 May 2024
- Clinical Textbook of Mood Disorders
- Clinical Textbook of Mood Disorders
- Copyright page
- Contents
- Contributors
- Foreword
- Chapter 1 Mood Disorders in the Twenty-First Century
- Chapter 2 The Classification of Mood Disorders and the Unipolar/Bipolar Dichotomy
- Chapter 3 Epidemiology of Mood Disorders across the Life Span
- Chapter 4 The Mood Spectrum Concept: Clinical Implications
- Chapter 5 Clinical Screening for Unipolar and Bipolar Disorders
- Chapter 6 The Socioeconomic Costs of Mood Disorders
- Chapter 7 Mood Disorders and Suicide
- Chapter 8 Mood and Psychosis: Limits and Overlapping between Psychotic Disorders and Mood Disorders
- Chapter 9 Transcultural Issues in Mood Disorders
- Chapter 10 Mood Disorders and Stress-Related Disorders
- Chapter 11 The Common Ancestors of Anxiety and Depression: Comorbidity as a Cognitive, Behavioural, Neural and Cellular Phenotype, and Current Evidence for Photobiomodulation as a Novel Treatment
- Chapter 12 Mood Disorders and Comorbid Substance Use Disorders
- Chapter 13 Mood Disorders with Attention-Deficit/Hyperactivity Disorder, Impulse Control Disorders, or Borderline Personality Disorder
- Chapter 14 Phenomenological Psychopathology of Mood Disorders
- Chapter 15 Brain Imaging in Mood Disorders: Pathophysiological Significance and Clinical Perspectives
- Chapter 16 Inflammation and Metabolic Issues in Mood Disorders
- Chapter 17 Genetics of Mood Disorders
- Chapter 18 Management of Major Depressive Disorder: Basic Principles
- Chapter 19 Treatment-Resistant Depression: Pharmacological Approach
- Chapter 20 An Update on the Treatment of Manic and Hypomanic States
- Chapter 21 The Burden of Bipolar Depression
- Chapter 22 The Management of Neurocognitive Impairment in Mood Disorders
- Chapter 23 Progress in Biomarkers to Improve Treatment Outcomes in Major Depressive Disorder
- Chapter 24 Pharmacogenomics and the Management of Mood Disorders
- Chapter 25 Mood Disorders: Therapeutic Challenges in the Medically Ill Patient
- Chapter 26 The Treatment of Mood Disorders in Children and Adolescents
- Chapter 27 Considerations about the Treatment of Mood Disorders in Elderly Patients
- Chapter 28 Evidence-Based Psychological Interventions for Bipolar Disorders
- Chapter 29 Evidence-Based Psychotherapeutic Approaches for Depressive Disorders
- Chapter 30 Rating Instruments for Mood Disorders in Clinical Practice
- Chapter 31 Service Delivery for Mood Disorders
- Index
- References
Summary
This chapter focuses on how recent advances in neuroimaging methods have increased our understanding of a key treatment for bipolar disorder, lithium. Structural magnetic resonance imaging (sMRI) studies suggest that lithium normalises both global and regional reductions in grey matter volume associated with bipolar disorder, while diffusion-weighted imaging (dMRI) studies have shed light on lithium’s potential to rectify abnormalities in white matter integrity. We describe the advent of direct imaging of lithium distribution in the brain using multinuclear MRI techniques (7Li-MRI) which is the first report of noninvasive imaging of a psychoactive drug in its target organ. The spatially heterogenous distribution of the 7Li-MR signal may suggest that lithium directly influences brain structure and function based on lithium tissue concentrations and initial work combining 7Li-MRI and dMRI support this hypothesis. Future directions of research are discussed, including harnessing the potential of multi-modal imaging and longitudinal study designs to develop combined biomarkers or biosignatures of response to treatment. Using lithium as an example, technological and scientific advances in brain imaging can facilitate treatment development and a personalised medicine approach in bipolar disorder.
Keywords
- Type
- Chapter
- Information
- Clinical Textbook of Mood Disorders , pp. 151 - 162Publisher: Cambridge University PressPrint publication year: 2024